4//SEC Filing
Drape Eric 4
Accession 0001209191-23-017157
CIK 0000818686other
Filed
Mar 7, 7:00 PM ET
Accepted
Mar 8, 4:04 PM ET
Size
7.9 KB
Accession
0001209191-23-017157
Insider Transaction Report
Form 4
Drape Eric
Executive VP Global Operations
Transactions
- Sale
Ordinary Shares
2023-03-07$9.43/sh−4,699$44,302→ 173,262 total - Sale
Ordinary Shares
2023-03-06$9.93/sh−1,566$15,552→ 177,961 total
Footnotes (5)
- [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- [F2]The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F3]Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units reported under Table II of the Form 4 filed by the reporting person with the SEC on March 7, 2023.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.86 to $10.045, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.37 to $9.725, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
Documents
Issuer
TEVA PHARMACEUTICAL INDUSTRIES LTD
CIK 0000818686
Entity typeother
Related Parties
1- filerCIK 0001790905
Filing Metadata
- Form type
- 4
- Filed
- Mar 7, 7:00 PM ET
- Accepted
- Mar 8, 4:04 PM ET
- Size
- 7.9 KB